Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocin-induced diabetes in rats.
about
Use of glucagon-like peptide-1 agonists to improve islet graft performanceCell transplantation: toward cell therapy.Article Commentary: Regenerative Medicine: An Analysis of Cell Transplantation's Impact.Challenges and emerging technologies in the immunoisolation of cells and tissues.In vitro culture duration does not impact the ability of encapsulated choroid plexus transplants to prevent neurological deficits in an excitotoxin-lesioned rat model of Huntington's disease.
P2860
Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocin-induced diabetes in rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Intrasplenic transplantation o ...... ocin-induced diabetes in rats.
@en
Intrasplenic transplantation o ...... ocin-induced diabetes in rats.
@nl
type
label
Intrasplenic transplantation o ...... ocin-induced diabetes in rats.
@en
Intrasplenic transplantation o ...... ocin-induced diabetes in rats.
@nl
prefLabel
Intrasplenic transplantation o ...... ocin-induced diabetes in rats.
@en
Intrasplenic transplantation o ...... ocin-induced diabetes in rats.
@nl
P2093
P2860
P1433
P1476
Intrasplenic transplantation o ...... ocin-induced diabetes in rats.
@en
P2093
Achilles A Demetriou
Hongxiang Hui
Jacek Rozga
Riccardo Perfettit
Sergio LiCalzi
Takeshi Aoki
Yutaka Umehara
P2860
P304
P356
10.3727/000000005783982990
P577
2005-01-01T00:00:00Z